Noctrix Health is developing novel device treatments for patients suffering from the debilitating symptoms of Restless Legs Syndrome. (RLS)
noctrixhealth.com
Treo Ventures Contact:
Tracy Pappas
CONTACT TRACY
Location: Pleasanton, CA
noctrixhealth.com
Treo Ventures Contact:
Tracy Pappas
CONTACT TRACY
Location: Pleasanton, CA
Location: United States
Total raised: $90.5M
Investors 5
| Date | Name | Website |
| - | Life Scien... | lifescienc... |
| - | Treo Ventu... | treovp.com |
| - | Bolt | portfolio.... |
| - | OrbiMed | orbimed.co... |
| - | Joyance Pa... | joyancepar... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 02.09.2025 | - | $33.5M | Sandbox In... |
| 16.01.2024 | Series C | $40M | - |
| 11.01.2021 | Series B | $17M | - |
Mentions in press and media 12
| Date | Title | Description |
| 02.09.2025 | Noctrix Health Raises Up To $33.5M in Debt and Equity Funding | Noctrix Health, a Pleasanton, CA-based developer of the Nidra Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS), raised up to $33.5M in debt and equity funding. Backers included Blue Venture Fund, and Sandbox Clinical ... |
| 03.10.2024 | Noctrix Health Announces Favorable Inclusion of Nidra Tonic Motor Activation (TOMAC) Therapy in New American Academy of Sleep Medicine (AASM) Clinical Practice Guidelines for Restless Legs Syndrome (R... | - |
| 19.08.2024 | Noctrix Health Announces New CMS Reimbursement Codes for Payment for Nidra Tonic Motor Activation (TOMAC) Therapy for Restless Legs Syndrome (RLS) | - |
| 16.01.2024 | Noctrix Health Completes $40M Series C Round | PLEASANTON, CA, Noctrix Health announced today that it has closed a $40 million Series C financing round. >> Click here for more funding data on Noctrix Health >> To export Noctrix Health funding data to PDF and Excel, click... |
| 16.01.2024 | Noctrix Health Raises $40M in Series C Financing | Nidra TOMAC therapy Noctrix Health, Inc., a Pleasonton, CA-based medical device company, closed a $40M Series C financing. The round was led by Sectoral Asset Management with participation from other new investors Angelini Ventures, ResMed,... |
| 16.01.2024 | Noctrix Health Secures $40 Million Series C Financing to Commercialize Novel Device Treatment For Restless Legs Syndrome (RLS) | - |
| 13.04.2023 | Where We Are Investing Now: Next-Gen Neurotech | Photo by Yan Krukau In a world awash in stress, neurotech that lifts mood, diminishes anxiety, deepens positive behavior and otherwise benefits individuals is supremely important. Even so, in terms of investment, this category faces tough ... |
| 02.10.2022 | Nurturing our Neuroscience Focus | Photo by Priyanka Singh on Unsplash Clearly, the ability to read, stimulate, or alter the patterns of the brain is core to the concept of delightful moments. Whether through relief from anxiety or stress, creation of calm or comfort, initi... |
| 25.05.2021 | Noctrix Health Announces Enrollment of First Patient in The RESTFUL Study and Publication of Positive Pilot Study Results | |
| 11.01.2021 | Noctrix Health, Inc. Completes $17 Million Series B Financing. | - |
Show more